India is a booming market for Clinical trials by Pharmaceutical companies. Many potential drugs and vaccines are tried on infants and on the poor population. The population in general is not aware of the provisions and the regulatory aspects of the clinical trials. Who regulates the clinical trials in India? Drug Controller General of India? Recently, there were several deaths of infants due to faulty clinical trials. The corporate world and other concerned (?) authorities are insensitive to such tragic incidents. Medical ethics is totally missing in this highly lucrative business of clinical trials.
What we need today is transparency in the clinical trial business. The results and the contact details of the investigators should be properly and adequately documented for verification. What about the insurance cover for such clinical trial deaths or disabilities? There are many questions which need answers from the companies and the national regulators. There is an urgent need for building up public confidence.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment